1. GBp


    Today's change

    -4.00 / -0.33%

    1 year change


    As of Aug 26 2016 17:05 BST. Data delayed by at least 20 minutes.

Search for Smith & Nephew PLC and
  1. FT Alphaville

    August 8, 2016

    FT Opening Quote: Executive pay soars

    Executive pay rises 10 per cent, YouGov upgrades trading expectations and Southern commuter misery. FT Opening Quote,...

  2. Fast FT

    August 8, 2016

    Smith & Nephew sells gynaecology unit; unveils $300m buyback

    Medical device-maker Smith & Nephew has offloaded its gynaecology business for $350m and unveiled a $300m share...

Special Reports

  1. Corporate Longevity

    The FT launches a global investigation into the mixture of innovation and focus that c...
Search more Special Reports on this topic.

  1. May 18, 2016

    Burberry: not so hot right now

    Parody fashion flick Zoolander 2 wasn’t funny and neither were Burberry’s annual results. Adjusted profits before tax...

  2. Fast FT

    May 18, 2016

    Smith & Nephew to launch $300m share buy-back

    Medical devices maker Smith & Nephew is planning to return $300m to shareholders through a share buyback, after...

  3. Fast FT

    May 5, 2016

    Smith & Nephew sales suffer in China and Gulf

    Weak demand in China has hit sales at Smith & Nephew, which makes sports medicine, implants and other medical devices....

  4. Fast FT

    April 28, 2016

    Shire (very) narrowly avoids defeat over pay proposals

    Investors in drugmaker Shire staged a rebellion over executive pay on Thursday, with 49.45 per cent of votes in a...

  5. April 17, 2016

    Tyrie urges investors to stand ground on executive pay

    Andrew Tyrie, Conservative MP and chairman of the influential Treasury committee, is urging investors to maintain their...

  6. February 4, 2016

    Smith & Nephew says results prove it can rival big groups

    Smith & Nephew says it has proved it can prosper in the shadow of bigger rivals such as Johnson & Johnson and Stryker...

  7. February 1, 2016

    Smith & Nephew chief Olivier Bohuon has ‘highly treatable’ cancer

    Smith & Nephew says chief executive Olivier Bohuon has been diagnosed with cancer but would remain in his post while...

  8. Fast FT

    February 1, 2016

    Opening Quote: Smith & Nephew, BT, EU/sardines

    Smith & Nephew says its CEO has a “highly treatable” form of cancer, BT is reshaping itself following its EE...

  9. FT Alphaville

    February 1, 2016

    FT Opening Quote

    Smith & Nephew says its CEO has a “highly treatable” form of cancer, BT is reshaping itself following its EE...

  10. Fast FT

    January 5, 2016

    Smith & Nephew completes robo-surgery acquisition

    The robot will see you now. UK medical devices maker Smith & Nephew has completed the purchase of Blue Belt Holdings...

  11. December 18, 2015

    Smith & Nephew shares boosted by takeover talk

    Smith & Nephew was the talking point on renewed speculation that it was a US bid target. The medical devices maker...

  12. November 10, 2015

    Beware the Ozymandias syndrome

    In May, Ed Miliband, leader of the UK’s Labour party at the time, made a last-ditch attempt to convince the electorate...

  13. October 11, 2015

    Olivier Bohuon insists Smith & Nephew can prosper on its own

    Is Smith & Nephew the one that got away? The UK medical device maker has long been seen as a potential target for...

  14. October 8, 2015

    Europe lacks non-execs with digital knowledge

    Trinity Mirror’s recent appointment of Facebook’s Steve Hatch as a non-executive director may suggest that UK company...

  15. September 21, 2015

    Smith & Nephew rises on takeover talk

    Smith & Nephew was among Monday’s gainers as takeover speculation was given another airing. S&N added 1.8 per cent to...

  16. FT Alphaville

    July 30, 2015

    FT Opening Quote - Banks challenged on Super Thursday of results

    It’s a Super Thursday of company results both in the UK and on the continent, so probably a good day to release bad...

  17. July 14, 2015

    Sir John Buchanan, scientist and finance chief, 1943-2015

    Sir John Buchanan, who has died aged 72, was a New Zealand-born scientist who rose to be finance director at BP before...

  18. May 1, 2015

    Smith & Nephew climbs on revival of bid talk

    A retread of Smith & Nephew bid speculation helped put the medical device maker among Friday’s gainers. S&N climbed 2.3...

  19. March 25, 2015

    FTSE slips, takeover premium for S&N ebbs

    The takeover premium continued ebbing out of Smith & Nephew on Wednesday, after management played down the chances of...

  20. March 3, 2015

    S&N dives as Stryker hopes fade

    Smith & Nephew led the London market lower on Tuesday after takeover hopes suffered a setback. Stryker, which examined...

  21. February 5, 2015

    Smith & Nephew ‘can prosper on its own’

    Smith & Nephew can prosper as a standalone company, its chief executive has insisted, brushing away takeover...

  22. January 11, 2015

    UBS loses two blue-chip corporate broking clients

    UBS has lost two more blue-chip corporate broking clients, in a further blow to the Swiss bank as it seeks to restore...

  23. November 24, 2014

    S&N hits record high on bid hopes

    Once again, the odds have shortened on orthopaedics maker Smith & Nephew losing its independence. S&N hit a record high...

  24. FT Alphaville

    October 17, 2014

    Familiarity breeds what again?

    A chart from Citi on the occasionally epic length of some auditing relationships on the back of the Tesco messiness: Of...

  25. October 15, 2014

    Pharma stocks slide on Shire deal doubts

    News that Abbvie’s £32bn deal to acquire Shire is in danger of failing to complete had deep repercussions on the FTSE...

  26. September 23, 2014

    London stocks hit by US tax crackdown

    London’s equity markets were lower for a second session this week, with drugmakers leading losses after US authorities...

  27. August 27, 2014

    Petrofac bounces on neutral FTSE 100

    Shares in Petrofac bounced back in early London trade on Wednesday, after the hit taken by the stock over the previous...

  28. August 6, 2014

    Pharma shares slide on fears of ‘tax inversion’ clampdown

    Investors fled global healthcare stocks on Wednesday after the Obama administration threatened action to halt the wave...

  29. August 6, 2014

    FTSE 100 bid stocks lead broad losses

    Stocks at the centre of recent bid activity faltered on the FTSE 100 on Wednesday, as jitters spread from news...

  30. June 16, 2014

    Medical device makers in a race to merge

    Medical device companies are eyeing more consolidation after Medtronic agreed to buy Covidien in a $42.9bn deal that...

  31. June 5, 2014

    Smith & Nephew jumps on takeover speculation

    Smith & Nephew remains the London market’s favourite gambling chip. The orthopaedic device maker spiked on Thursday,...

  32. May 30, 2014

    Smith & Nephew lifted by deal talk

    Smith & Nephew hit a record closing high on Friday on hopes that the orthopaedics maker has been put into play. UBS...

  33. May 29, 2014

    UK lesson for Stryker and Pfizer

    Twice in two weeks, US companies interested in buying UK groups have walked away after coming up against British...

  34. May 29, 2014

    Smith & Nephew pushed into deal frenzy

    Smith & Nephew was pushed firmly into the deal frenzy gripping the healthcare industry on Thursday after its US rival...

  35. May 29, 2014

    Smith & Nephew shares rise after Stryker confirms bid work

    Shares of Smith & Nephew rose 2.7 per cent in early trading on Thursday after the chief executive of Stryker confirmed...

  36. May 1, 2014

    Smith & Nephew dismisses fears of threat from consolidated rivals

    The chief executive of Smith & Nephew shrugged off fears of stronger competition from rivals in the medical products...

  37. April 28, 2014

    Bid moves boost European stock markets

    AstraZeneca’s shares jumped in early trading on Monday after Pfizer confirmed it had made a renewed approach for the UK...

  38. March 28, 2014

    Break-up talk pushes S&N higher

    Break-up speculation lifted Smith & Nephew on Friday. S&N rose 2.4 per cent to 921.5p after Investec Securities said...

Search for Smith & Nephew PLC and